Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2014 Financial Results March 25, 2015
Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for Opioid Dependence November 20, 2014
Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2014 Financial Results November 7, 2014
Titan Pharmaceuticals Announces Enrollment Reaches Halfway Mark in Phase 3 Study of Probuphine for Opioid Dependence September 23, 2014
